News

$6M Gift from Family of Roblox Creator Launches New Initiative to Advance CAR T Therapy

UC San Francisco has launched the Baszucki Lymphoma Therapeutics Initiative to increase the effectiveness and availability of chimeric antigen receptor T-cell (CAR T) therapy for lymphoma patients. Jan Ellison Baszucki and her husband, Roblox CEO David Baszucki, gifted $6 million over five years to...

Living Therapeutics Initiative Announces Director of Scientific Programs

Cammie Edwards, PhD, has been appointed Director of Scientific Programs for the UCSF Living Therapeutics Initiative (LTI).

Beyond CAR-T: New Frontiers in Living Cell Therapies

Our cells have abilities that go far beyond the fastest, smartest computer. They generate mechanical forces to propel themselves around the body and sense their local surroundings through a myriad of channels, constantly recalibrating their actions. 

UCSF Forum on Living Therapeutics and Cellular Manufacturing

UCSF Chancellor Sam Hawgood, Helen Diller Family Comprehensive Cancer Center President Alan Ashworth, and faculty present this video introduction to UCSF’s institutional commitment to, and vision for, living therapeutics and cellular manufacturing. Living therapeutics, also called cell therapy, is...

Cell therapy 'jigsaw puzzle' fits together in $250M UCSF initiative

UCSF is launching a broad initiative spanning its research, clinical and newly created manufacturing infrastructure aimed at producing cutting-edge cell therapies against a range of cancers, autoimmune diseases and rare genetic diseases.

Living Therapeutics Initiative Will Accelerate Development and Delivery of Revolutionary Treatments

The Living Therapeutics Initiative (LTI) will bring together UCSF’s vast scientific and clinical expertise to accelerate research and quickly advance promising therapies to clinical trials for patients who have few, if any, good treatment options. As a federation of established UCSF initiatives,...

Thermo Fisher and University of California look to cut costs and speed up adoption of cell therapies

Thermo Fisher Scientific Inc and the University of California, San Francisco (UCSF) have formed a alliance to accelerate the development and manufacturing of cell-based therapies.   Read more

Thermo Fisher partners with UCSF to provide a one-stop shop for early biotech manufacturing

The team at Thermo Fisher Scientific wants to help beef up the manufacturing capabilities of smaller biotechs, and it’s enlisting the University of California, San Francisco to do so. Thermo Fisher will outfit a 44,000 square-foot cell therapy center on the school’s Mission Bay campus, serving as...

Thermo Fisher Scientific and UCSF to Open Cell Therapy cGMP Manufacturing and Collaboration Center

Thermo Fisher Scientific Inc., the world leader in serving science, and UC San Francisco announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies. 

In major cell therapy manufacturing deal, UCSF, biotech tools leader Thermo Fisher go small to go big

The new cell therapy manufacturing facility, which will open early next year, will be able to deliver highly specialized cell therapies to patients in clinical trials at UCSF's women's, children's and cancer hospitals complex across Mariposa Street.